Publication Details
Issue: Vol 2, No 1 (2025)
Pages: 71-79
ISSN: 2997-7347
Abstract
As a result of the studies, no bleeding or adverse effects on the cardiovascular system (recurrent myocardial infarction, stroke, etc.) were observed during treatment with Controloc. The drug was well tolerated in almost all patients. Complications of erosive and ulcerative lesions of the gastrointestinal mucosa, such as bleeding, were absent in all patients.
Keywords
cardiovascular diseases
blood loss
bleeding
gastrointestinal tract
stomach diseases
stomach ulcers
anticoagulant therapy
antiplatelet therapy